Treatment Arm

Visit number vs Troponin-I, high-sensitivity
N Mean StdDev Median Min Max Unknown Total
Baseline 315 10.2 ± 31.3 5.4 1.5 464.2 3 318
Follow-up 294 9.5 ± 21.0 5.3 1.9 226.1 7 301
Treatment Arm vs Troponin-I, high-sensitivity
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 315 10.2 ± 31.3 5.4 1.5 464.2 3 318
Healthy Lifestyles and Sleep Education - control arm (HLSE) 104 9.8 ± 26.1 5.2 2.2 261.4 2 106
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) 105 9.8 ± 15.8 6.1 1.5 137.2 1 106
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) 106 10.9 ± 44.8 5.0 2.0 464.2 - 106
Treatment Arm vs Troponin-I, high-sensitivity
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 294 9.5 ± 21.0 5.3 1.9 226.1 7 301
Healthy Lifestyles and Sleep Education - control arm (HLSE) 98 9.7 ± 23.2 5.4 1.9 226.1 2 100
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) 99 10.9 ± 26.0 5.6 2.0 207.8 2 101
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) 97 7.8 ± 10.2 4.9 2.2 78.3 3 100
Age category vs Troponin-I, high-sensitivity
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 315 10.2 ± 31.3 5.4 1.5 464.2 3 318
45-54 years 53 6.0 ± 5.7 4.3 2.0 39.3 - 53
55-64 years 137 12.6 ± 45.2 5.6 2.3 464.2 2 139
65 years or older 125 9.3 ± 14.5 6.1 1.5 137.2 1 126
Age category vs Troponin-I, high-sensitivity
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 294 9.5 ± 21.0 5.3 1.9 226.1 6 300
45-54 years 48 6.0 ± 4.5 4.5 1.9 24.4 1 49
55-64 years 124 9.4 ± 21.9 5.1 2.0 226.1 3 127
65 years or older 122 10.9 ± 23.7 5.7 2.2 207.8 2 124
Gender of the participant vs Troponin-I, high-sensitivity
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 315 10.2 ± 31.3 5.4 1.5 464.2 3 318
Female 83 6.6 ± 8.1 3.9 2.0 55.8 1 84
Male 232 11.4 ± 36.1 5.9 1.5 464.2 2 234
Gender of the participant vs Troponin-I, high-sensitivity
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 294 9.5 ± 21.0 5.3 1.9 226.1 7 301
Female 78 5.8 ± 4.8 4.0 2.0 29.7 1 79
Male 216 10.8 ± 24.2 5.7 1.9 226.1 6 222
Race of the participant vs Troponin-I, high-sensitivity
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 314 10.2 ± 31.3 5.4 1.5 464.2 3 317
White 255 10.8 ± 34.6 5.4 1.5 464.2 1 256
American Indian or Alaskan Native 2 4.0 ± 0.5 4.0 3.6 4.3 - 2
Black or African American 42 8.6 ± 7.6 5.9 2.0 39.3 1 43
Asian 6 5.7 ± 3.8 4.4 2.4 12.5 - 6
Native Hawaiian or other Pacific islander 1 3.9 - 3.9 3.9 3.9 - 1
Other 3 3.7 ± 0.9 3.4 3.1 4.7 1 4
Multiple 5 6.3 ± 6.5 3.8 2.7 18.0 - 5
Race of the participant vs Troponin-I, high-sensitivity
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 293 9.5 ± 21.0 5.3 1.9 226.1 6 299
White 237 10.0 ± 23.2 5.3 1.9 226.1 4 241
American Indian or Alaskan Native 2 7.3 ± 4.8 7.3 3.9 10.7 - 2
Black or African American 39 8.1 ± 5.6 6.6 2.0 23.4 2 41
Asian 6 5.1 ± 2.9 4.1 2.8 10.6 - 6
Native Hawaiian or other Pacific islander 1 3.9 - 3.9 3.9 3.9 - 1
Other 3 5.2 ± 2.8 4.0 3.2 8.3 - 3
Multiple 5 5.7 ± 5.0 3.9 2.5 14.5 - 5